New England Journal of Drugs will get swept up in U.S. lawyer inquiry

Final week, no less than one scientific journal acquired a letter from a prime U.S. lawyer asking it to answer alleged bias. Now, one of many world’s main medical journals, has acquired an analogous inquiry as properly. 

The New England Journal of Drugs’s editor in chief, Eric Rubin, acquired a letter from the interim U.S. lawyer for the District of Columbia, Edward R. Martin Jr. in latest days wherein the prosecutor requested six questions, largely about alleged bias within the resolution to publish unspecified content material. The journal informed STAT it responded by affirming its dedication to evidence-based suggestions and editorial independence.

“As practising physicians, our editors acknowledge our accountability to medical doctors and sufferers. We use rigorous peer evaluate and editorial processes to make sure the objectivity and reliability of the analysis we publish,” Rubin wrote in his response. “We assist the editorial independence of medical journals and their First Modification rights to free expression. The Journal actively fosters scholarly scientific dialogue and stays steadfast in its dedication to supporting authors, readers, and sufferers.”